Hypertension in women.

Area of Science:

• Cardiology
• Public Health
• Women's Health

Background:

• Hypertension is more prevalent in women than men, particularly due to increased longevity and population numbers.
• Specific conditions like white coat hypertension, fibromuscular hyperplasia, and primary aldosteronism are more common in women.
• Risk factors unique to women include oral contraceptives, obesity, and hormone replacement therapy's impact on cardiovascular health.

Purpose of the Study:

• To explore the gender-specific epidemiology and clinical course of essential hypertension.
• To examine variations in treatment response and outcomes between men and women.
• To highlight the importance of gender in understanding and managing hypertension.

Main Methods:

• Review of existing literature on hypertension in women versus men.
• Analysis of epidemiological data and clinical outcomes.
• Consideration of physiological and lifestyle factors influencing hypertension in women.

Main Results:

• Women experience higher rates of hypertension, with specific causes and risks differing from men.
• Left ventricular hypertrophy presents a greater mortality risk in women.
• Non-pharmacologic therapies are effective adjuncts, and certain medications (ACE inhibitors, ARBs) are contraindicated in pregnancy.

Conclusions:

• Hypertension management requires a gender-sensitive approach, considering unique risk factors and physiological differences in women.
• Non-pharmacologic interventions are foundational, with careful consideration of medication safety, especially for women of childbearing potential.
• Addressing hypertension disparities, particularly among Black women, remains a critical public health objective.